[Calcium receptor/calcium-sensing receptor].
Nagano
Nobuo
N
D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism / Q000502:physiology; D000069449:Cinacalcet; D002986:Clinical Trials as Topic; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000209:etiology; D009154:Mutation; D009281:Naphthalenes / Q000627:therapeutic use; D010627:Phenethylamines; D011437:Propylamines; D044169:Receptors, Calcium-Sensing / Q000819:agonists / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D015398:Signal Transduction
D000814:Aniline Compounds; C107873:N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; D009281:Naphthalenes; D010627:Phenethylamines; D011437:Propylamines; D044169:Receptors, Calcium-Sensing; D002118:Calcium; D000069449:Cinacalcet